Research / ACNT / Fundamental state Inspectable configuration
State dimensions Filing 0000095953-21-000032 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
23.97% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 60th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.46% · OPTIONAL · VALID
Operating cash generation 60th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
7.02% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-16.11% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 10th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
33.23% · OPTIONAL · VALID
Gross margin 20th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.gross_margin
8.85% · CORE · VALID
Operating margin 20th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.operating_margin
-12.14% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.20% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 80th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.70% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 33 states Self-history eligible
Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/8 normalized Level 3 Mar 31, 2026 7/8 normalized Level 3 Jun 30, 2026 7/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 120.38%
Current 23.97%
Delta -96.41% Capex Intensity Increased
Previous 1.44%
Current 1.46%
Delta 0.02% Cash Generation Decreased
Previous 10.37%
Current 7.02%
Delta -3.34% Growth Increased
Previous -19.52%
Current -16.11%
Delta 3.41% Inventory Pressure Decreased
Previous 150.18%
Current 33.23%
Delta -116.95% Margin Increased
Previous 8.43%
Current 8.85%
Delta 0.42% Profitability Increased
Previous -21.22%
Current -12.14%
Delta 9.08% Sbc Intensity Increased
Previous 0.51%
Current 0.70%
Delta 0.19% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.